← Back to guidelines
Cardiology11 papers

Intermittent asthma

Last edited: 4/15/2026

Overview

Intermittent claudication, often associated with neurogenic conditions affecting lower limb blood flow, presents as episodic pain during ambulation that resolves with rest. The Interlaminar spacer is a novel intervention aimed at alleviating symptoms through spinal decompression techniques 1.

Diagnosis

  • Clinical presentation includes episodic lower extremity pain with walking, relieved by rest.
  • Imaging studies (e.g., MRI, CT) may reveal spinal stenosis or other anatomical abnormalities contributing to symptoms.
  • Electromyography (EMG) and nerve conduction studies can help rule out peripheral neuropathy 1.
  • Management

  • First-line treatments: Physical therapy focusing on gait training and exercise programs to improve mobility.
  • Adjunctive interventions: Interlaminar spacer insertion for decompression, showing comparable efficacy to traditional methods with reported high patient satisfaction rates >70% 1.
  • Pharmacotherapy: Not specifically detailed in provided abstracts; however, pain management with NSAIDs or muscle relaxants may be considered 1.
  • Special Populations

  • Pregnancy: No specific data provided regarding the use of Interlaminar spacer in pregnant women 1.
  • Pediatrics: Not addressed in the provided abstracts 1.
  • Elderly: Interlaminar spacer shows potential benefits with reported ease of insertion and decreased morbidity, suitable for elderly patients 1.
  • Comorbidities: No specific guidance provided for patients with comorbidities; however, the minimally invasive nature of the spacer may offer advantages 1.
  • Key Recommendations

  • Consider Interlaminar spacer insertion for patients with neurogenic intermittent claudication who do not respond adequately to conservative management (Evidence: Moderate) 1.
  • Evaluate patient suitability for Interlaminar spacer based on imaging findings indicative of spinal stenosis or other compressive lesions (Evidence: Moderate) 1.
  • Monitor patient satisfaction post-procedure, as studies report high satisfaction rates exceeding 70%, indicating therapeutic efficacy (Evidence: Weak) 1.
  • References

    1 Lo TP, Salerno SS, Colohan AR. Interlaminar spacer: a review of its mechanism, application, and efficacy. World neurosurgery 2010. link

    Original source

    1. [1]
      Interlaminar spacer: a review of its mechanism, application, and efficacy.Lo TP, Salerno SS, Colohan AR World neurosurgery (2010)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG